BioGenerator Company Wugen Raises $172 Million to Advance Memory NK Cell Platform, AML Program, and Initiate Multiple Solid Tumor Trials

BioGenerator Company Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial

› PR Newswire

BioGenerator Company Plastomics adds Key Industry Veteran to R&D Team

BioGenerator Company Aclaris Therapeutics Announces Positive Data from Trial in Atopic Dermatitis

› Biospace

BioGenerator Company Benson Hill Going Public in $2 Billion SPAC Merger

› Wall Street Journal

BioGenerator Company Galera Therapeutics Announces Updated Data from Pancreatic Cancer Trial

BioGenerator Company Arch Oncology Closes $105M Series C Financing

SBIR/STTR Training

BioGenerator Company Neurolutions Receives FDA Authorization For Brain-Computer-Interface Device